2022 - 2025 Statistical Analysis on Healthcare Inequality by COVID-19
2018 - 2020 医療費自己負担率の引き上げが医療の不平等性にもたらす影響についての実証分析
2018 - 2020 小児慢性疾患患者に対する医療福祉政策の実証研究ー1型糖尿病を例としてー
2016 - 2020 Micro-Quantitative Economic Analysis of Drug Pricing System
2016 - Health Economic Study on the Cost of Type 1 Diabetes and Government Aid in Japan
2015 - 医療イノベーションと医療保険財政の両立に向けた民間保険の役割と意義
2015 - 保険償還価格決定の不透明性が研究開発インセンティブに与える影響の考察
Show all
Papers (10):
Sayaka SAKODA, Masaoki Tamura, Naohiko Wakutsu. What Discourages Adults’ Use of Insulin-Infusion Pumps in Japan, Habit or Financial Aid?. International Journal of Economic Policy Studies. 2023. 17. 331-345
Naohiko Wakutsu, Emi Hirose, Naohiro Yonemoto, Sven Demiya. Assessing Definitions and Incentives Adopted for Innovation for Pharmaceutical Products in Five High-Income Countries: A Systematic Literature Review. Pharmaceutical Medicine. 2023. 37. 53-70
Hiroshi Nakamura, Naohiko Wakutsu, Satoshi Murayama, Takeshi Suzuki. An Empirical Analysis of Japan's Drug Development Lag Behind the United States. Journal of Clinical Pharmacology. 2022. 62. 7. 847-857
Sayaka Sakoda, Masaoki Tamura, Naohiko Wakutsu. The Global Financial Crisis and Healthcare Inequality in Japan. Social Indicators Research. 2022. 161. 273-286
Hiroshi Nakamura, Naohiko Wakutsu. Indonesian Pharmaceutical Market and Business Opportunities for Japanese Pharmaceutical Industry (Investigation Report from the Industry-Government-Academia Round Table Discussion Project). Journal of Health and Society. 2017. 26. 4. 423-428
Does "Drug Lag" Still Exist in Japan? An Empirical Analysis of the Development Lag behind the U.S.”
(EUHEA Conference 2020 2020)
Does "Drug Lag" Still Exist in Japan? An Empirical Analysis of the Development Lag behind the U.S.
(18th International Conference of the Japan Economic Policy Association 2019)
Does ‘Drug Lag’ Still Exist in Japan? An Empirical Analysis of Development Lag in Japan behind the U.S.
(14th Annual Meeting of Japan Health Economics Association 2019)